Navigation Links
Transgenomic, Inc. Reports First Quarter 2009 Results
Date:5/13/2009

OMAHA, Neb., May 13 /PRNewswire-FirstCall/ -- Transgenomic, Inc. (OTC Bulletin Board: TBIO) today announced financial results for the first quarter ended March 31, 2009. The Company's financial results are presented in the tables that follow.

The Company reported a net loss of $953,000 or $.02 per share for the first quarter of 2009 as compared to a net income of $122,000 or $0.00 per share for the first quarter of 2008.

Net sales from continuing operations were $5.0 million during the first quarter 2009, compared to $6.3 million during the comparable period of 2008. Gross profit from continuing operations was $2.8 million or 56 percent during the first quarter of 2009 compared to $3.6 million or 58 percent during the comparable period of 2008. Operating expenses from continuing operations were $3.8 million during the first quarter of 2009 compared to $3.5 million during the same period of 2008. Excluding the impact of foreign currency revaluation gains/losses, operating expenses were down by $0.1 million in the first quarter of 2009 compared to the same period of 2008. Cash and cash equivalents totaled $4.8 million at March 31, 2009.

Comment and Outlook

Craig Tuttle, the Company's President and Chief Executive Officer, noted "Unfortunately, like many companies today, we are also experiencing an impact from the overall economic slowdown. This resulted in a decline in first quarter revenue to $5.0 million compared to our first quarter revenues in 2008 of $6.3 million and a net loss of $1.0 million in the quarter. This decline was primarily the result of a slowdown in instrument orders compared to what we experienced throughout 2008. Our Molecular Diagnostics Laboratory grew from $.9 million to $1.0 million in revenue in the first quarter of 2009 compared to the fourth quarter of 2008. The Molecular Diagnostics Laboratory grew by $447,000 over the first quarter of 2008. We have added an addi
'/>"/>

SOURCE Transgenomic, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Transgenomic, Inc. Reports Second Quarter 2007 Results
2. Transgenomic, Inc. Forms Scientific Advisory Board
3. Transgenomic, Inc. Reports Third Quarter 2008 Results
4. Transgenomic, Inc. Reports Fourth Quarter and Fiscal Year 2008 Results
5. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
6. QMed, Inc. Reports July Medicare SNP Enrollments
7. Phlo Affiliate Reports Expanded Coverage to Oregon Border
8. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Carrington Reports Second Quarter 2007 Results
11. Avitar Reports Third Quarter Financial Results for Fiscal 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...24 Blue Marble Energy Corp. announ...evelopment Authority (OPDA) were recently awarded ...c Revitalization Board (CERB) in a private/public ...ty biochemical biorefinery in Lincoln County, WA. ...the development of our biorefinery and bring over ...
(Date:11/24/2009)...efficacy endpoint has been met for patients with a... , QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall...Z) (the "Company"), a global biopharmaceutical com...day announced positive efficacy data from a Phase ...ate, AEZS-108 (formerly AN-152), in patients with ...
(Date:11/24/2009)...ovember 24 Shire plc (LS...pharmaceutical company, today,announced that it ha... for,velaglucerase alfa, the company,s enzyme repl...f Type 1 Gaucher disease. This is the third market...en submitted, with previous,submissions in the Uni...
(Date:11/24/2009)..., Calif., Nov. 24 Genomi...at Randy Scott, Genomic Health,s Executive Chairma...ealth Care Conference in New York City on Tuesday,...ss the live and subsequently archived webcast of t...ion of Genomic Health,s website at http://investo...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...sed by the Elderly and Patients With Movement Diso...ngs , , HAIFA, Israel, May 18 Millions of people... their ability to walk. For many of them, traditio...isappointing substitute for being able to walk nor...igh-tech yet easy-to-use gait-training device, the...
...NTA, May 18 /PRNewswire-Asia/ -- Global biomedical...ion in Singapore in the year 2008. This rides on,S...omedical sciences R&D,expenditure exceeding US...ce in Singapore points to the city-state,s,attract...he fast growing Asian,market to fuel their growth....
...javik, ICELAND, May 17 In a paper published,today...sts from deCODE,genetics (Nasdaq: DCGN ) and acad...erlands present the discovery of single letter var... that influence the age of girls at menarche, the,...nfluenced by both genetic,and environmental factor...
Other Biology Technology:Now Available: State-of-the-Art Gait Training Device to Help Millions Walk More Normally Again 2Biomedical Sciences Companies Expanding in Asia Invested More Than US$500 Million in Singapore 2Biomedical Sciences Companies Expanding in Asia Invested More Than US$500 Million in Singapore 3Biomedical Sciences Companies Expanding in Asia Invested More Than US$500 Million in Singapore 4Biomedical Sciences Companies Expanding in Asia Invested More Than US$500 Million in Singapore 5deCODE Study Shows Complex Interplay of the Human Biological Clock With Height, Weight and Disease 2deCODE Study Shows Complex Interplay of the Human Biological Clock With Height, Weight and Disease 3deCODE Study Shows Complex Interplay of the Human Biological Clock With Height, Weight and Disease 4
(Date:11/25/2009)...niversity assistant professors recently received f...to continue research beneficial to understanding t..., Christopher Blackwood, assistant professor in t...grants to support two separate research projects. ...ecomposer Communities and Functions from the Leaf ...
(Date:11/24/2009)... years it has been prescribed by traditional heale...daches and stomach pain to fever and flu. , Now f...sity have been able to scientifically prove the pa...wise known as Brazilian mint. , Testing this anci...esearcher Graciela Rocha was able to show that whe...
(Date:11/24/2009)...s opening new doors to understanding how sounds as...of a marine mammal or if they hear it at all. , ...nners that NASA uses to detect flaws in the space ...ing scientists to peek inside the giant head of a ...nsional replicas of a whale,s hearing anatomy usin...
Breaking Biology News(10 mins):Kent State University professors focus research on the environment with grants totaling $890,000 2Got a pain? -- Have a cup of Brazilian mint 2Rocket science leads to new whale discovery 2Reflective film can boost profits for apple growers 10621 1Reflective film can boost profits for apple growers 10621 2Sustainably grown garlic 10616 1Sustainably grown garlic 10616 2Sustainably grown garlic 10616 3Trauma Deadlier for Kids Without Insurance 60632 1Trauma Deadlier for Kids Without Insurance 60632 2
... Calif. (March 9, 2009)A minimally invasive interv...ively uses oxygen/ozone to relieve the pain of her...tes in the next few years, predict researchers at ...ual Scientific Meeting. In a related study, the in...relieves the pain associated with herniated disks....
...he largest study of its kind to evaluate the effec...oncludes that both are equal offenders when it com...f the study, led by researchers at Fred Hutchinson...ch issue of Cancer Epidemiology, Biomarkers and P...ed wine,s effects on breast-cancer risk. There is ...
...500,000 snippets of human DNA put scientists from ...ic variant on chromosome 8 occurs with significan...palate than in the control group. The results are ...urnal Nature Genetics . , Cleft lips and palates... One in about 700 babies in Central Europe are aff...
Other Biology News:Oh, my aching back: Give me a shot of ozone 2Oh, my aching back: Give me a shot of ozone 3Red wine vs. white? It makes no difference when it comes to breast-cancer risk 2Cleft lip and palate: Genes more important than thought? 2
...bus is a flexible, fully automated microplate stri...to its fully automated microplate strip washing ca...ith excellent performance and ease of operation. ...de manifolds of 8, 12 or 16 channels, crosswise as...
...Label Transfer Sulfo SBED Protein:Protein Interact...Transfer has rapidly gained traction as an in vitr...ing number of publications feature the exclusive P...agent to study a variety of issues relating to pro...
... Incubator is a compact benchtop and stackable mul...ntroller with a large display screen to accurately...ulation inside to evenly distribute temperature in...ed from the microprocessor controller. Built in ma...
Human siTrio from B-Bridge International
Biology Products: